The lab-made 3D liver model serves as a human relevant platform for analyzing the progressive stages of the liver disease, ...
Researchers at Science Tokyo have created a lab-grown liver organoid that mimics regeneration and scarring, offering a new ...
Commercial, paid medical screening like blood tests, whole body MRIs and DEXA scans, which can evaluate bone density and ...
Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025 New clinical data from the MATCH Phase II study shows early ...
1 Arroyo V et al., Nat. Rev. Dis. Primers 2 (2016) 2 Elafibranor is marketed and commercialized, notably in the U.S and Europe, by Ipsen under the trademark Iqirvo® 3 On October 30, 2025 GENFIT ...
"This fundamentally changes how we think about the evolution of complex nervous systems," said biologist Jack Ullrich-Lüter.
Scientists at Georgia State University have used CRISPR gene editing to restore an ancient enzyme humans lost millions of years ago potentially reversing the buildup of uric acid that causes gout.
Fibre intake and the health of the human gut empowers key immune cells to act as “careful snipers” in protecting the body ...
12hon MSN
New Wonder Drug Could Keep Us Young
A UK team claims to have cracked one of life's oldest mysteries - how to stop the body breaking down with age - and is now ...
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS(R) in HER2 lung cancer
Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results